19 results

243 Who should be offered non-radical surgery for early-stage cervical cancer?
Geneviève Bouchard-Fortier, Allan Covens
J Gynecol Oncol. 2015;26(4):243-245.   Published online 2015 October 12    DOI: http://dx.doi.org/10.3802/jgo.2015.26.4.243
246 Wait times from diagnosis to treatment in cancer
Laurie Elit
J Gynecol Oncol. 2015;26(4):246-248.   Published online 2015 September 23    DOI: http://dx.doi.org/10.3802/jgo.2015.26.4.246
249 Uterine carcinosarcoma/malignant mixed Müllerian tumor incidence is increased in women with breast cancer, but independent of hormone therapy
Brian T. Wilson, Heather J. Cordell
J Gynecol Oncol. 2015;26(4):249-251.   Published online 2015 September 23    DOI: http://dx.doi.org/10.3802/jgo.2015.26.4.249
252 A critical assessment on the role of sentinel node mapping in endometrial cancer
Giorgio Bogani, Antonino Ditto, Fabio Martinelli, Mauro Signorelli, Stefania Perotto, Domenica Lorusso, Francesco Raspagliesi
J Gynecol Oncol. 2015;26(4):252-254.   Published online 2015 October 8    DOI: http://dx.doi.org/10.3802/jgo.2015.26.4.252
255 Pretreatment risk factors for parametrial involvement in FIGO stage IB1 cervical cancer
Hiroyuki Yamazaki, Yukiharu Todo, Kazuhira Okamoto, Katsushige Yamashiro, Hidenori Kato
J Gynecol Oncol. 2015;26(4):255-261.   Published online 2015 July 14    DOI: http://dx.doi.org/10.3802/jgo.2015.26.4.255
262 Longer waiting times for early stage cervical cancer patients undergoing radical hysterectomy are associated with diminished long-term overall survival
Kulisara Nanthamongkolkul, Jitti Hanprasertpong
J Gynecol Oncol. 2015;26(4):262-269.   Published online 2015 September 23    DOI: http://dx.doi.org/10.3802/jgo.2015.26.4.262
270 Pulmonary metastasectomy in uterine malignancy: outcomes and prognostic factors
E Sun Paik, Aera Yoon, Yoo-Young Lee, Tae-Joong Kim, Jeong-Won Lee, Duk-Soo Bae, Byoung-Gie Kim
J Gynecol Oncol. 2015;26(4):270-276.   Published online 2015 July 17    DOI: http://dx.doi.org/10.3802/jgo.2015.26.4.270
277 Controversies in the management of endometrial cancer: a survey of the Korean Gynecologic Oncology Group
Jung-Yun Lee, Kidong Kim, Taek Sang Lee, Sokbom Kang, Seok Ju Seong, Jae Weon Kim, Byoung-Gie Kim
J Gynecol Oncol. 2015;26(4):277-283.   Published online 2015 September 23    DOI: http://dx.doi.org/10.3802/jgo.2015.26.4.277
284 Adjuvant sequential chemo and radiotherapy improves the oncological outcome in high risk endometrial cancer
Mauro Signorelli, Andrea Alberto Lissoni, Elena De Ponti, Tommaso Grassi, Serena Ponti, Robert Fruscio
J Gynecol Oncol. 2015;26(4):284-292.   Published online 2015 July 14    DOI: http://dx.doi.org/10.3802/jgo.2015.26.4.284
293 Synchronous and metachronous malignancy in endometrial cancer patients treated in a tertiary care center of Thailand
Siriwan Tangjitgamol, Jakkapan Khunnarong, Sunamchok Srijaipracharoen
J Gynecol Oncol. 2015;26(4):293-302.   Published online 2015 July 17    DOI: http://dx.doi.org/10.3802/jgo.2015.26.4.293
303 Clinical significance of systematic retroperitoneal lymphadenectomy during interval debulking surgery in advanced ovarian cancer patients
Haruko Iwase, Toshio Takada, Chiaki Iitsuka, Hidetaka Nomura, Akiko Abe, Tomoko Taniguchi, Ken Takizawa
J Gynecol Oncol. 2015;26(4):303-310.   Published online 2015 July 17    DOI: http://dx.doi.org/10.3802/jgo.2015.26.4.303
311 Palonosetron versus granisetron in combination with aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with gynecologic cancer
Satoe Fujiwara, Yoshito Terai, Satoshi Tsunetoh, Hiroshi Sasaki, Masanori Kanemura, Masahide Ohmichi
J Gynecol Oncol. 2015;26(4):311-319.   Published online 2015 July 20    DOI: http://dx.doi.org/10.3802/jgo.2015.26.4.311
320 Clinical application of sartorius tendon transposition during radical vulvectomy: a case control study of 58 cases at a single institution
Lei Li, Xinxin Kou, Xiaojie Feng, Fenghua Liu, Hongtu Chao, Liying Wang
J Gynecol Oncol. 2015;26(4):320-326.   Published online 2015 September 23    DOI: http://dx.doi.org/10.3802/jgo.2015.26.4.320
327 Identification of high-affinity VEGFR3-binding peptides through a phage-displayed random peptide library
Li-Feng Shi, Yan Wu, Cai-Yun Li
J Gynecol Oncol. 2015;26(4):327-335.   Published online 2015 July 17    DOI: http://dx.doi.org/10.3802/jgo.2015.26.4.327
336 Role of aggressive surgical cytoreduction in advanced ovarian cancer
Suk-Joon Chang, Robert E. Bristow, Dennis S. Chi, William A. Cliby
J Gynecol Oncol. 2015;26(4):336-342.   Published online 2015 July 17    DOI: http://dx.doi.org/10.3802/jgo.2015.26.4.336
343 Controversies in borderline ovarian tumors
Seok Ju Seong, Da Hee Kim, Mi Kyoung Kim, Taejong Song
J Gynecol Oncol. 2015;26(4):343-349.   Published online 2015 September 23    DOI: http://dx.doi.org/10.3802/jgo.2015.26.4.343
350 Fertility-sparing surgery in high-risk ovarian cancer
Antonino Ditto, Giorgio Bogani, Fabio Martinelli, Francesco Raspagliesi
J Gynecol Oncol. 2015;26(4):350-351.   Published online 2015 July 17    DOI: http://dx.doi.org/10.3802/jgo.2015.26.4.350
352 Surgical staging of para-aortic LN in patients with locally advanced cervix cancer and no evidence of metastases in preoperative PET/CT imaging
Ming Yin Lin, Thomas W. Jobling, Kailash Narayan
J Gynecol Oncol. 2015;26(4):352-354.   Published online 2015 September 23    DOI: http://dx.doi.org/10.3802/jgo.2015.26.4.352
355 Staging classification for cancer of the ovary and the fallopian tube should include in situ carcinoma
Wiebren A. A. Tjalma
J Gynecol Oncol. 2015;26(4):355-356.   Published online 2015 September 23    DOI: http://dx.doi.org/10.3802/jgo.2015.26.4.355
Articles from Journal of Gynecologic Oncology are provided here courtesy of Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology